Immune Therapeutics, Inc.
IMUN · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,536 | $3,586 | $1,589 | -$3,397 |
| Dep. & Amort. | $0 | $0 | $1 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | $702 | $683 | $1,012 | $3,350 |
| Other Non-Cash | $2,252 | -$4,500 | -$2,793 | $44 |
| Operating Cash Flow | -$582 | -$232 | -$192 | -$1 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$500 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$500 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $738 | $716 | $197 | $0 |
| Financing Cash Flow | $738 | $716 | $197 | $0 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$343 | $484 | $5 | -$1 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $494 | $10 | $5 | $6 |
| End Cash | $150 | $494 | $10 | $5 |
| Free Cash Flow | -$1,082 | -$232 | -$192 | -$1 |